TTY Biopharm Company Limited (TPEX:4105)

TTY Biopharm Company Statistics

Total Valuation

TPEX:4105 has a market cap or net worth of TWD 18.38 billion. The enterprise value is 17.77 billion.

Market Cap	18.38B
Enterprise Value	17.77B

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	Mar 27, 2025

Share Statistics

TPEX:4105 has 248.65 million shares outstanding. The number of shares has increased by 0.04% in one year.

Current Share Class	n/a
Shares Outstanding	248.65M
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	11.80%
Owned by Institutions (%)	11.63%
Float	192.71M

Valuation Ratios

The trailing PE ratio is 12.70 and the forward PE ratio is 15.08.

PE Ratio	12.70
Forward PE	15.08
PS Ratio	3.12
PB Ratio	2.45
P/TBV Ratio	2.88
P/FCF Ratio	15.01
P/OCF Ratio	13.62
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.94, with an EV/FCF ratio of 14.51.

EV / Earnings	12.26
EV / Sales	3.01
EV / EBITDA	8.94
EV / EBIT	9.90
EV / FCF	14.51

Financial Position

The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.23.

Current Ratio	2.02
Quick Ratio	1.56
Debt / Equity	0.23
Debt / EBITDA	1.08
Debt / FCF	1.40
Interest Coverage	36.43

Financial Efficiency

Return on equity (ROE) is 21.68% and return on invested capital (ROIC) is 9.91%.

Return on Equity (ROE)	21.68%
Return on Assets (ROA)	8.40%
Return on Invested Capital (ROIC)	9.91%
Return on Capital Employed (ROCE)	17.42%
Revenue Per Employee	17.23M
Profits Per Employee	4.24M
Employee Count	342
Asset Turnover	0.57
Inventory Turnover	2.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.84% in the last 52 weeks. The beta is -0.02, so TPEX:4105's price volatility has been lower than the market average.

Beta (5Y)	-0.02
52-Week Price Change	-1.84%
50-Day Moving Average	76.28
200-Day Moving Average	74.73
Relative Strength Index (RSI)	51.70
Average Volume (20 Days)	1,190,655

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4105 had revenue of TWD 5.89 billion and earned 1.45 billion in profits. Earnings per share was 5.82.

Revenue	5.89B
Gross Profit	3.41B
Operating Income	1.39B
Pretax Income	1.89B
Net Income	1.45B
EBITDA	1.59B
EBIT	1.39B
Earnings Per Share (EPS)	5.82

Balance Sheet

The company has 3.08 billion in cash and 1.71 billion in debt, giving a net cash position of 1.37 billion or 5.51 per share.

Cash & Cash Equivalents	3.08B
Total Debt	1.71B
Net Cash	1.37B
Net Cash Per Share	5.51
Equity (Book Value)	7.51B
Book Value Per Share	27.15
Working Capital	2.93B

Cash Flow

In the last 12 months, operating cash flow was 1.35 billion and capital expenditures -125.16 million, giving a free cash flow of 1.22 billion.

Operating Cash Flow	1.35B
Capital Expenditures	-125.16M
Free Cash Flow	1.22B
FCF Per Share	4.92

Margins

Gross margin is 57.94%, with operating and profit margins of 23.65% and 24.60%.

Gross Margin	57.94%
Operating Margin	23.65%
Pretax Margin	31.99%
Profit Margin	24.60%
EBITDA Margin	26.95%
EBIT Margin	23.65%
FCF Margin	20.77%

Dividends & Yields

This stock pays an annual dividend of 4.20, which amounts to a dividend yield of 5.64%.

Dividend Per Share	4.20
Dividend Yield	5.64%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	2
Payout Ratio	60.03%
Buyback Yield	-0.04%
Shareholder Yield	5.60%
Earnings Yield	7.89%
FCF Yield	6.66%

Stock Splits

The last stock split was on August 13, 2014. It was a forward split with a ratio of 1.067.

Last Split Date	Aug 13, 2014
Split Type	Forward
Split Ratio	1.067

Scores

TPEX:4105 has an Altman Z-Score of 5.18.

Altman Z-Score	5.18
Piotroski F-Score	n/a